Gastroenterology Research and Practice / 2016 / Article / Tab 6

Research Article

Clinical Presentation, Risk Factors, and Treatment Modalities of Hepatocellular Carcinoma: A Single Tertiary Care Center Experience

Table 6

Univariate and multivariate cox regression analysis of variables associated with poor survival in HCC patient.

Univariate analysisMultivariate analysis
valueHR95.0% CI valueHR95.0% CI
LowerUpperLowerUpper

Symptomatic cases02.1571.5013.101
Nonviral hepatitis0.0221.6171.0732.437
Multiple tumor (≥3)0.002.9962.0194.4460.0002.6791.5774.552
Metastasis0.005.1953.2428.324
Vascular invasion0.003.8492.256.586
CTP (B)0.002.671.8133.93
CTP (C)0.004.312.5317.339
BCLC (C)0.0018.7764.38280.4450.0446.2831.05237.545
BCLC (D)0.00110.9212.5147.5110.0002.6791.5774.552
Portal vein thrombosis0.004.9233.0647.91
AGE0.001.0391.0191.060.0001.0481.0231.074
AST0.001.0041.0031.0050.0001.0061.0031.009
ALT0.0311.00211.0050.0010.9930.9890.997
BMI0.0240.9640.9340.995
Tumor size0.001.0781.0451.111
Albumin0.000.9470.9220.972
Creatinine0.0331.00211.004
Platelets0.0061.0021.0011.003
MELD0.001.0691.0451.094

CTP: Child-Turcotte-Pugh score; BCLC: Barcelona Clinic Liver Cancer; MELD: model for end-stage liver disease; AST: aspartate aminotransferase; ALT: alanine aminotransferase; BMI: body mass index.

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.